Cellectar to participate in the oppenheimer fall healthcare life sciences & medtech summit

Florham park, n.j., sept. 15, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that james caruso, president and ceo, will present a company overview at the following upcoming conference:
CLRB Ratings Summary
CLRB Quant Ranking